C2 blood levels in heart-transplanted patients immunosuppressed on a trough level-;based regimen (original) (raw)
Cyclosporin C2 and C0 concentration monitoring in stable, long-term heart transplant recipients receiving metabolic inhibitors
Andrew McLachlan
The Journal of Heart and Lung Transplantation, 2003
View PDFchevron_right
C2 monitoring in maintenance renal transplant recipients: is it worthwhile?
Einar Svarstad
Transplantation, 2003
View PDFchevron_right
C2 monitoring of cyclosporine in de novo liver transplant recipients: The clinician's perspective
Stephen Pollard
Liver Transplantation, 2004
View PDFchevron_right
Cyclosporine monitoring in renal transplant recipients with induction therapy: C2 levels in patients monitored on C0
Gilles Paintaud
Fundamental and Clinical Pharmacology, 2006
View PDFchevron_right
Cyclosporine dose reduction in stable renal transplant patients with high C2 level: simplified method of single C2 measurement and individualization of C0 target
Rob Higgins
Transplant International, 2005
View PDFchevron_right
Cyclosporine monitoring in the early post-transplant period in pediatric liver transplant recipients
Javier Murcia
Pediatric Transplantation, 2007
View PDFchevron_right
Conversion to C 2 monitoring of cyclosporine A exposure in maintenance kidney transplant recipients: Results at 3 years
Giuseppe Grandaliano
American Journal of Kidney Diseases, 2004
View PDFchevron_right
C2 is superior to C0 as predictor of renal toxicity and rejection risk profile in stable heart transplant recipients
Gino Gerosa
Transplant International, 2005
View PDFchevron_right
Association of Calculated Area under the Curve or Cyclosporine C0 and C2 Level Monitoring in Pediatric Renal Transplant Patients
Gokhan Moray
International Journal of Transplantation Research and Medicine, 2021
View PDFchevron_right
Neoral C2 monitoring in maintenance liver transplant patients: A step forward?
Gary Levy
Liver Transplantation, 2004
View PDFchevron_right
Neoral dose monitoring with cyclosporine 2-hour postdose levels in heart transplant patients receiving anti-thymocyte globulin induction
Patrick Ergina, M. Salvadori
Transplantation Proceedings, 2000
View PDFchevron_right
New strategies of cyclosporine monitoring in heart transplantation
martin ortiz
Transplantation Proceedings, 2003
View PDFchevron_right
Cyclosporine dose fractioning might affect renal function in stable heart transplanted patients
U. Livi
Transplantation Proceedings, 2001
View PDFchevron_right
clinical benefit of monitoring cyclosporine C2 and C4 in long-term liver transplant recipients
Rakesh Rai
Transplantation Proceedings, 2002
View PDFchevron_right
Monitoring of Cyclosporine 2Hour PostDose Levels in Heart Transplantation: Improvement in Clinical Outcomes
Diego Delgado
Journal of Heart and Lung Transplantation, 2005
View PDFchevron_right
C2 monitoring of cyclosporine in stable heart transplant patients after two daily and three daily doses
U. Livi
Transplantation Proceedings, 2002
View PDFchevron_right
The risk of coronary artery disease after heart transplantation is increased in patients receiving low-dose cyclosporine, regardless of blood cyclosporine levels
Michele Senni
Clinical Cardiology, 1997
View PDFchevron_right
Clinical outcomes and C2 cyclosporin monitoring in maintenance renal transplant recipients: 1 year follow-up study
Julio Pascual
Nephrology Dialysis Transplantation, 2005
View PDFchevron_right
A Randomized, Controlled Trial of C0- Vs C2-guided Therapeutic Drug Monitoring of Cyclosporine in Stable Heart Transplant Patients
William Borland
The Journal of Heart and Lung Transplantation, 2005
View PDFchevron_right
Target range maximum of cyclosporine blood concentration two hours post dose in stable liver transplant patients
Uta Dahmen
European journal of medical research
View PDFchevron_right
A Multicenter, Prospective Study of C2-Monitored Cyclosporine Microemulsion in a U.S. Population of De Novo Renal Transplant Recipients
Johann Jonsson
Transplantation, 2005
View PDFchevron_right
Cyclosporine Therapeutic Monitoring With C MAX in Kidney Transplant Recipients: Impact of Schistosomal Infection
mohamed nassar
Dialysis & Transplantation, 2009
View PDFchevron_right